Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells.
Oncol Lett
; 19(6): 3950-3958, 2020 Jun.
Article
in En
| MEDLINE
| ID: mdl-32382339
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Oncol Lett
Year:
2020
Type:
Article